• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

6 Marijuana Stocks We're Watching Today - November 7th, 2017

November 7, 2017

 

Out of over 200 marijuana stocks, there's 6 that we're going to be watching as the markets open due to breaking news out this morning. Here's 6 cannabis companies to watch today including Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF) and more.

 

Aurora Cannabis Inc. (TSX:ACB) (OTC:ACBFF)

 

Today, Aurora Cannabis Inc. announced that it's partnership with Namaste Technologies Inc. is off to a good start, with over 200 orders in the first three days since the launch.

 

CannaRoyalty Corp. (CSE:CRZ) (OTC:CNNRF)

 

This morning, CannaRoyalty Corp. announced that it signed a letter of intent with Æther Gardens for the launch of CR Brands products into the Nevada market through AEG with a focus on Las Vegas.

 

Canopy Growth Corp. (TSX:WEED) (OTC:TWMJF)

 

This morning, Canopy Growth Corp. announced that it has signed a definitive licensing agreement with Farm to Farma Inc. for FTF's innovative Trokie® lozenges. Under this licensing agreement, Canopy Growth will have the exclusive right to manufacture and distribute FTF's Trokie® lozenges through its subsidiaries in Canada.

 

Cure Pharmaceutical Holding Corp. (OTC:CURR)

 

This morning, Therapix Biosciences Ltd. announced that it has entered into a product development agreement with Cure Pharmaceutical Holding Corp. focusing on the development of cannabinoid-based treatments on CURE’s patented, multilayer oral thin film (OTF), CureFilm™, for the treatment of a wide range of sleep disorders.

 

Namaste Technologies Inc. (CSE:N) (OTC:NXTTF)

 

Today, Aurora Cannabis Inc. announced that it's partnership with Namaste Technologies Inc. is off to a good start, with over 200 orders in the first three days since the launch.

 

Therapix Biosciences Ltd. (NASDAQ:TRPX)

 

This morning, Therapix Biosciences Ltd. announced that it has entered into a product development agreement with Cure Pharmaceutical Holding Corp. focusing on the development of cannabinoid-based treatments on CURE’s patented, multilayer oral thin film (OTF), CureFilm™, for the treatment of a wide range of sleep disorders.

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, YouTube, and Instagram.

 

D/M/O

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.